97153 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa Plasmodium
AUTOMATED HEART VALVE MANUFACTURING
#2ANTIGEN BINDING PROTEIN AND USES THEREOF
#3NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
#4PFCSP-BASED IMMUNOGENS AND RELATED COMPOSITION AND METHODS
#5AUTOMATED HEART VALVE MANUFACTURING
#6NANOBODY-DRUG ADDUCTS AND USES THEREOF
#7TARGETED DRUG DELIVERY-RELEASE AND KILLING OF DRUG RESISTANT TUMORS AND PATHOGENS
#8NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
#9Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof
#10System, method, apparatus and diagnostic test for plasmodium vivax
#11DNA ANTIBODY CONSTRUCTS FOR USE AGAINST PLASMODIUM PARASITES
#12METHODS OF RESTORING FUNCTIONAL CAPACITY AND LINEAGE COMPOSITION OF AN AGING BLOOD AND VASCULAR SYSTEM
#13Antibodies to PfGARP kill malaria parasites and protect against infection and severe disease
#14Automated heart valve manufacturing
#15Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
#16NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE
#17COMPOSITIONS AND METHODS FOR TARGETING PLASMODIUM MALE GAMETE PROTEIN TO BLOCK MALARIA PARASITE TRANSMISSION
#18Anti-PfRH5 antibodies and antigen-binding fragments thereof
#19Vaccine for falciparum malaria
#20Automated heart valve manufacturing
#21ANTI-CSP ANTIBODIES
#22ANTIBODIES BINDING TO PLASMODIUM CIRCUMSPOROZOITE PROTEIN AND USES THEREOF
#23PLASMODIUM VIVAX MALE GAMETE FUSION PROTEIN PVHAP2 AND THE PUTATIVE PROLIFERATING-CELL NUCLEOLAR ANTIGEN P120 AS RELAPSE BIOMARKERS
#24NOVEL METHODS OF GENERATING ANTIBODIES
#25Anti-CSP antibodies
#26PLASMODIUM ANTIBODIES
#27Automated heart valve manufacturing devices and methods
#28TREATMENT AND PREVENTION OF MALARIA
#29Neutralizing antibodies to circumsporozoite protein and their use
#30ANTI-CSP ANTIBODY VARIANTS
#31MALARIA ANTIGENS ON THE SURFACE OF ERYTHROCYTES AND MEROZOITES AND PROTECTIVE ANTIBODIES
#32Anti-plasmodium falciparum HRP-II antibody
#33Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
#34Vaccine for falciparum malaria
#35MALARIA VACCINE AND METHODS FOR PRODUCING SAME
#36Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use
#37Antibodies to PfGARP kill malaria parasites and protect against infection and severe disease
#38Chimeric antigen receptor and application thereof
#39System, method, apparatus and diagnostic test for
#40Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#41USES OF PARASITE MACROPHAGE MIGRATION INHIBITORY FACTORS
#42Anti-PfRH5 antibodies and antigen-binding fragments thereof
#43and vaccine
#44SYSTEM, METHOD, APPARATUS AND DIAGNOSTIC TEST FOR PREGNANCY
#45PLASMODIUM FALCIPARUM AND PLASMODIUM VIVAX VACCINE
#46PLASMODIUM SPOROZOITE NPDP PEPTIDES AS VACCINE AND TARGET NOVEL MALARIA VACCINES AND ANTIBODIES BINDING TO
#47Malaria vaccine and methods for producing same
#48Vaccine for falciparum malaria
#49Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use
#50Malaria vaccine
#51Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
#52COMPOSITIONS COMPRISING CelTOS IMMUNOGENS AND ANTIBODIES AND METHOD OF USE THEREOF
#53Compositions and methods for detection of malaria biomarkers
#54IDENTIFICATION AND PRODUCTION OF HIGH AFFINITY IGM ANTIBODIES AND DERIVATIVES THEREOF
#55Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#56Anti-malarial compositions
#57Anti-malarial antibodies that bind circumsporozoite protein
#58Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof
#59IMMUNOASSEMBLIN (IA) PROTEIN COMPLEXES
#60Methods of generating antibodies
#61PROTEINS COMPRISING A MUTATED LAIR-1 FRAGMENT AND USES THEREOF
#62EXTENDED PROTECTION PROTEIN VACCINES AGAINST INFECTIOUS AGENTS
#63Anti-plasmodium parasite antibodies
#64COMPOSITION AND USES THEREOF
#65Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#66Mosquito saliva protein malaria vaccine
#67Vaccine for falciparum malaria
#68Vaccine for malaria
#69Anti-parasitic complexes
#70Three-component-multistage malaria vaccine
#71Treatment and prevention of malaria
#72Multi-component-multistage malaria vaccines
#73Uses of parasite macrophage migration inhibitory factors
#74AMA-1 epitopes, antibodies, compositions, and methods of making and using the same
#75Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#76Anti-malarial compositions
#77Vaccine comprising AMA1 and RON2
#78Composition and uses thereof
#79Treatment and prevention of malaria
#80Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof
#81Treatment and prevention of malaria
#82Adenovirus vectors
#83Peptide and Antibody Test Material for Detecting Both Vivax Malaria and Falciparum Malaria
#84USE OF P47 FROM PLASMODIUM FALCIPARUM (PFS47) OR PLASMODIUM VIVAX (PVS47) AS A VACCINE OR DRUG SCREENING TARGETS FOR THE INHIBITION OF HUMAN MALARIA TRANSMISSION
#85Anti-plasmodium parasite antibodies
#86Anti-malarial compositions
#87Expression vectors for cell-surface expression of polypeptides comprising a transmembrane domain of glycophorin A
#88Malaria vaccine
#89Diagnosis, prognosis, and treatment of kidney disease
#90Adaptive immunity profiling and methods for generation of monoclonal antibodies
#91IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
#92Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#93Treatment and prevention of malaria
#94RECOMBINANT PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEINS 4 AND 5 AND THEIR USE
#95hybrid circumsporozoite protein and vaccine
#96Recombinantly expressed CelTOS antigen and methods of use thereof
#97Nanoparticle Based Immunological Stimulation
#98Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof
#99Recombinant merozoite surface proteins 4 and 5 and their use
#100Adenovirus vectors
#101Immunogenic compositions and diagnostic and therapeutic uses thereof
#102Adaptive immunity profiling and methods for generation of monoclonal antibodies
#103Methods of using multimeric complexes of antigens and an adjuvant
#104hybrid circumsporozoite protein and vaccine
#105Malaria vaccine
#106Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection
#107METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES
#108Binding domain of reticulocyte binding proteins
#109RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1
#110Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from carrying a Glycosyl-phosphatidyl-inositol group (GPI)
#111Polynucleotides and polypeptides involved in gestational malaria, and biological applications
#112LSA-5 liver stage and blood stage antigen of , immunogenic composition comprising said antigen, and vaccines against malaria
#113PLASMODIUM FALCIPARUM ANTIGENS INDUCING PROTECTIVE ANTIBODIES
#114Recombinant merozoite surface proteins 4 and 5 and their use
#115Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
#116Recombinant merozoite protein-1vaccine
#117METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES
#118Methods and compositions for treating and preventing malaria (2)
#119hybrid circumsporozoite protein and vaccine
#120METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA
#121Multimeric complexes of antigens and an adjuvant
#122Recombinant merozoite surface proteins 4 and 5 and their use
#123DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
#124IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#125Recombinant merozoite protein-1vaccine
#126Plasmodium vivax blood stage antigens, PVESP-1, antibodies and diagnostic assays
#127Vaccines for blocking transmission of
#128Immunogenic agent and pharmaceutical composition for use against homologous and heterologous pathogens including plasmodium SPP
#129Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
#130Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1
#131Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines
#132Method of screening
#133antigens inducing protective antibodies
#134Peptide sequences specific for the hepatic stages of bearing epitopes capable of stimulating the T lymphocytes
#135Method of promoting an immune response with a bispecific antibody
#136Immunogenic compositions and diagnostic and therapeutic uses thereof
#137Expression, purification and uses of a liver stage antigen 1 polypeptide
#138Recombinant protein containing a C-terminal fragment of MSP-1
#139Malarial pre-erythrocytic stage polypeptide molecules
#140Vaccine based on a cellular penetration factor from an apicomplexan parasite
#141Carboxypeptidases B from anopheles gambiae. compositions comprising them, vaccine applications and use as therapeutical targets
#142Antibodies which bind to proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes
#143Recombinant anti-antibodies